AuntMinnie

JUNE 26, 2023

NorthStar Medical Radioisotopes is routinely manufacturing copper-67(Cu-67. Read more on AuntMinnie.com Related Reading: NorthStar appoints new president/CEO NorthStar installs accelerator at its new Wisc.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals Medical IT 52

Radiology Business

AUGUST 5, 2024

Telix Pharmaceuticals Ltd. announced the news on July 31, with the decision applying to its TLX250-CDx investigational agent for clear cell renal cell carcinoma (brand name Zircaix).

Pharmaceutical 106

Pharmaceutical Imaging IT 106

Keosys Medical Imaging

AUGUST 26, 2024

With her large experience in the pharmaceutical industry, Helen Blanco currently serves as Chief Operating Officer at Node Pharma , a preclinical radiopharmaceutical company based in Norway. We recently spoke with Helen about the key criteria when selecting an imaging vendor and exciting upcoming innovations in the oncology space.

Pharmaceutical 98

Pharmaceutical Radiopharmaceuticals Imaging Medical Imaging 98

Imaging Technology

AUGUST 29, 2023

Administration of the therapeutic dose took place as part of an ongoing Phase I/IIa theranostic clinical trial conducted by Clarity Pharmaceuticals to investigate the safety and efficacy of Cu-67 SARTATE in pediatric patients with high-risk neuroblastoma.

Pharmaceutical 97

Pharmaceutical Radiopharmaceuticals Clinic Medical 97

Open Medscience

OCTOBER 1, 2024

Good Manufacturing Practices ensure the consistent quality, safety, and efficacy of pharmaceutical products through rigorous production standards. The post Overview of Good Manufacturing Practices (GMP) in Radiopharmaceuticals appeared first on Open MedScience.

Radiopharmaceuticals 52

Radiopharmaceuticals Pharmaceutical 52

Radiology Business

DECEMBER 18, 2023

Telix Pharmaceuticals recently submitted its license application to the FDA for the investigational positron emission tomography agent TLX250-CDx (Zircaix).

Pharmaceutical 108

Pharmaceutical Imaging IT 108

Open Medscience

SEPTEMBER 30, 2024

Q9(R1) Quality Risk Management provides a comprehensive framework for assessing, controlling, and mitigating pharmaceutical quality risks. The post Q9(R1) Quality Risk Management: Final FDA Guidance for Industry appeared first on Open MedScience.

Risk Management 52

Risk Management Pharmaceutical Radiopharmaceuticals 52

Health Imaging

DECEMBER 8, 2023

The vaccine delivery method relies on an acoustic effect called "cavitation" to deliver such pharmaceuticals.

Pharmaceutical 124

Pharmaceutical Ultrasound 124

Radiology Business

AUGUST 26, 2024

The Swiss pharmaceutical firm operates Europe’s second largest network of cyclotrons, used to manufacture radioactive compounds needed for PET scans.

PET Scan 59

PET Scan Pharmaceutical Imaging 59

Radiology Business

SEPTEMBER 20, 2023

Backers include societies representing radiologists and nuclear medicine professionals, device manufacturers, patient advocacy groups, and pharmaceutical companies.

Nuclear Medicine 102

Nuclear Medicine Pharmaceutical Diagnostic Imaging Diagnostic 102

Diagnostic Imaging

JULY 5, 2023

The prospective multicenter trial, which is slated to begin patient recruitment in late 2023, will reportedly assess the ability of 64Cu SAR-bisPSMA to diagnose prostate cancer within pelvic lymph nodes.

Pharmaceutical 58

Pharmaceutical Diagnose 58

Radiology Business

FEBRUARY 27, 2024

Progenics Pharmaceuticals Inc. claims MIM stole its patents and used them to help entice GE HealthCare to buy the company in January.

Pharmaceutical 94

Pharmaceutical Radiology Healthcare Healthcare 94

AuntMinnie

OCTOBER 18, 2024

Australia-based Telix Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) to list its ordinary shares and trade on the Nasdaq under the ticker symbol “TLX.” Telix is not proposing to raise capital or issue any new shares, it said.

Pharmaceutical 98

Pharmaceutical IT Diagnostic Imaging 98

AuntMinnie

MAY 28, 2024

Telix Pharmaceuticals has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for a new prostate-specific membrane antigen (PSMA)-PET cold kit for prostate cancer imaging.

Pharmaceutical 98

Pharmaceutical Imaging 98

AuntMinnie

JUNE 10, 2024

Emery has more than 30 years of experience in financial executive leadership in the pharmaceutical and medical device industries. Prior to that, he led financial executive teams at Plasma Surgical and Abbott Pharmaceuticals. He was previously CFO and chief operating officer (COO) at Tyber Medical.

Pharmaceutical 52

Pharmaceutical Medical Device Ultrasound Medical 52

AuntMinnie

MAY 19, 2024

He will oversee Lantheus’ research and development organization, including research and pharmaceutical development, regulatory affairs, clinical development, medical affairs, and isotope strategy. He has spent more than two decades working for pharmaceutical companies such as Bayer, Bristol-Myers Squibb, Kyowa Kirin, and Pfizer.

Pharmaceutical 52

Pharmaceutical Medical Imaging Medical Clinic 52

AuntMinnie

SEPTEMBER 18, 2024

Telix Pharmaceuticals has selected Cardinal Health to distribute its PET agent TLX250-CDx (Zircaix) for imaging kidney cancer in the U.S., subject to its regulatory approval.

Pharmaceutical 59

Pharmaceutical Disease Diagnostic IT 59

MRI Network

MARCH 25, 2024

Big data has become a pillar in modern pharmaceutical practices. Pharmaceutical companies have also leveraged big data in third-party collaborations, resulting in more efficient product deployment and customer experiences. Industry experts predict the pharmaceutical analytical testing market could total an estimated USD 8.98

Pharmaceutical 59

Pharmaceutical Quality and Compliance Clinic Diagnostic 59

AuntMinnie

DECEMBER 3, 2023

Telix Pharmaceuticals is highlighting that the first patient has been dosed with the company's TLX250-CDx (Zr-89 DFO-girentuximab) for clear cell renal cell carcinoma, the most common and aggressive form of kidney cancer.

Pharmaceutical 97

Pharmaceutical Medical IT Radiology 97

AuntMinnie

JULY 24, 2024

Produced by the ACR Committee on Drugs and Contrast Media, the new manual features four updates: An update and addition of Ferumoxytol as a new MRI contrast medium for Chapter 12 – Contrast Media in Children An update for Chapter 13 - Gastrointestinal (GI) Contrast Media in Adults: Indications and Guidelines An evidence-based update with recommendations (..)

Pharmaceutical 73

Pharmaceutical MRI Healthcare Healthcare 73

AuntMinnie

AUGUST 22, 2024

Food and Drug Administration (FDA) has granted Clarity Pharmaceuticals fast-track designation for its copper-64 (Cu-64) sarcophagine (SAR) bisPSMA radiopharmaceutical.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals Disease Clinic 52

AuntMinnie

APRIL 13, 2023

Fusion Pharmaceuticals has secured clearance from the U.S. Read more on AuntMinnie.com Related Reading: Fusion heralds FDA tumor therapy clearance Fusion and Niowave ink $5M collaboration Fusion Pharmaceuticals to build radiopharma plant in Canada Fusion buys radiopharmaceutical from Ipsen Food and Drug Administratio.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals 52

AuntMinnie

JANUARY 21, 2024

Bayer has appointed Nelson Ambrogio as its new head of radiology business in its pharmaceuticals division. Ambrogio will serve on Bayer's pharmaceuticals executive committee and be based in Berlin, Germany; he will report to Stefan Oelrich, who is a member of the company's board of management and president of its pharmaceuticals division.

Pharmaceutical 40

Pharmaceutical Radiology IT 40

AuntMinnie

JULY 31, 2024

The company’s Pharmaceutical Diagnostics segment generated $639 million in second-quarter revenues, a 14% increase on an organic basis over last year, GE HealthCare reported. Pharmaceutical Diagnostics segment EBIT was $200 million, up 31% over last year. Segment EBIT was $178 million, down 7% from the second quarter of 2023.

Healthcare 52

Healthcare Healthcare Pharmaceutical Ultrasound 52

AuntMinnie

AUGUST 27, 2024

Telix Pharmaceuticals has submitted a new drug application (NDA) with the U.S. Food and Drug Administration (FDA) for its PET radiotracer TLX101-CDx (Pixclara) for imaging brain cancer.

Pharmaceutical 52

Pharmaceutical Imaging IT 52

Open Medscience

JANUARY 12, 2024

Radiopharmaceuticals, combining radioactive and pharmaceutical elements, enable precise diagnosis and treatment in nuclear medicine. The post The Transformative Impact of Radiopharmaceuticals in Medical Imaging appeared first on Open Medscience.

Radiopharmaceuticals 52

Radiopharmaceuticals Medical Imaging Nuclear Medicine Medical 52

Imaging Technology

FEBRUARY 14, 2024

PanTera is committed to supporting the pharmaceutical industry by scaling up production to meet the significant global demand for targeted radiopharma-based therapeutics in the fight against cancer.”

Pharmaceutical 105

Pharmaceutical Radiopharmaceuticals Medical Clinic 105

AuntMinnie

JULY 18, 2024

Melbourne, Australia-based Telix Pharmaceuticals reported a spike in revenue for the second quarter of 2024, citing strong sales of Illuccix (gallium-68 prostate-specific membrane antigen [PSMA]-11), its PSMA-PET radiotracer kit for prostate cancer imaging.

Pharmaceutical 52

Pharmaceutical IT Imaging 52

Radiology Business

APRIL 17, 2023

For one pharmaceutical company, a plan to independently source barium and iodine from North America may offer protection from global supply chain disruptions.

Pharmaceutical 65

Pharmaceutical Imaging 65

AuntMinnie

JUNE 2, 2024

Telix Pharmaceuticals has completed the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for its new PET agent, TLX250-CDx. TLX250-CDx (Zircaix) characterizes renal masses as clear cell renal cell carcinoma, the company said.

Pharmaceutical 52

Pharmaceutical IT 52

Imaging Technology

JUNE 15, 2023

For pharmaceutical companies and researchers, using this tracer to better understand the mechanism of action - i.e. the effect of immunotherapies on a patient’s immune response to their cancer - could, potentially, enable them to better select patients to participate in clinical trials and bring new immunotherapies to market.

Radiopharmaceuticals 98

Radiopharmaceuticals Pharmaceutical Nuclear Medicine PET Scan 98

AuntMinnie

JUNE 23, 2023

Radiopharmaceutical developer Actinium Pharmaceuticals is highlighting six researc. Read more on AuntMinnie.com Related Reading: Actinium, Astellas to create actinium-225 radiotherapies Zevacor signs on as manufacturing partner for Actinium

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals 52

AuntMinnie

JULY 24, 2023

Radiopharmaceutical developer Clarity Pharmaceuticals has reached 50% recruitmen.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals 52

Imaging Technology

JULY 25, 2024

An active DMF enables clinical investigators or pharmaceutical companies to reference the filing in their regulatory submissions. DMFs are submissions to FDA used to provide confidential, detailed information about facilities, processes or articles used in the manufacturing, processing, packaging and storing of human drug products.

Medical 105

Medical Radiopharmaceuticals Pharmaceutical Clinic 105

AuntMinnie

AUGUST 31, 2023

Radiotherapy developer Actinium Pharmaceuticals will present three abstract. Read more on AuntMinnie.com Related Reading: Actinium highlights six abstracts at SNMMI 2023 Actinium, Astellas to create actinium-225 radiotherapies SNMMI 2020: PET tracer could image, treat glioblastoma Zevacor signs on as manufacturing partner for Actinium

Pharmaceutical 52

Pharmaceutical Imaging 52

AuntMinnie

JULY 8, 2024

He brings more than 25 years of experience from GE HealthCare (GEHC), where he served for 25 years in a variety of roles, including executive director and global head of contrast media; general manager, pharmaceutical diagnostics North America; and president.

Diagnostic 40

Diagnostic Pharmaceutical Healthcare Healthcare 40

AuntMinnie

MAY 29, 2024

The end-to-end care continuum is designed to support clinicians and promote developments for lung health in the pharmaceutical and medical device industries. will unveil its lung care continuum at the ASCO annual meeting. It features AI tools that identify, measure, manage, and monitor lung health developments.

X-ray 52

X-ray Pharmaceutical Medical Device Clinic 52